Acquires of Minaris Regenerative Medicine by Altaris, a US healthcare fund (represented Altaris) Home Practices Acquires of Minaris Regenerative Medicine by Altaris, a US healthcare fund (represented Altaris) Period September, 2024 Practices M&A People Kenichi Sekiguchi Kenichi Sekiguchi Partner Tokyo +81-3-6266-8562 kenichi.sekiguchi@morihamada.com M&A Corporate Law Asset Management / Funds Dispute Resolution Yasutaka Tokuda Yasutaka Tokuda Partner Tokyo +81-3-6266-8934 yasutaka.tokuda@morihamada.com M&A Crisis Management / Compliance Life Sciences / Healthcare Consumer Law Public Policy Masaaki Hirota Masaaki Hirota Partner Tokyo +81-3-6266-8985 masaaki.hirota@morihamada.com M&A Structured Finance / Banking Fumiya Sunose Fumiya Sunose Senior Associate Tokyo +81-3-5223-7791 M&A Corporate Law Yurika Inoue Yurika Inoue Senior Associate Tokyo +81-3-6213-8163 M&A Life Sciences / Healthcare Intellectual Property Corporate Law Related Cases August, 2025 Investment into Chocolate Pte. Ltd., a Fintech company in Singapore, by Nikko Asset Management Tetsu Takeuchi Norihito Sato Yui Kanemitsu August, 2025 Mori Hamada represented EQT in its take private transaction of CareNet Kenichi Sekiguchi Masaki Kakimoto Kensuke Sakajiri Yuki Tominaga August, 2025 Case Highlights Mori Hamada represented the special committee in a going private transaction of TechnoPro Holdings by Blackstone Kenichi Sekiguchi Kensuke Sakajiri July, 2025 Case Highlights EQT: Acquisition of Fujitec for USD 2.7 billion Kenichi Sekiguchi Shimpei Ochi Masaki Kakimoto Norimitsu Mori Kensuke Sakajiri Yusuke Kurachi July, 2025 Represented GENDA in connection with its acquisition of mini-location business from VENUplus Nobuhiko Suzuki Stan Yukevich Masataka Hayano Eugene Chao July, 2025 Case Highlights Investment by ORIX Corporation in Robotruck Inc. and business alliance between ORIX Auto Corporation and Robotruck Inc. Norihito Sato Hiroyuki Tanaka Norimitsu Mori Go back to Cases